News for Healthier Living

Novel CAR-T Therapy for Hard-to-Treat Multiple Myeloma Shows Promising Safety and Durable Responses

A phase 1 clinical trial found that an investigational CAR-T therapy can lead to deep and durable responses in people with relapsed or refractory multiple myeloma.

September 30, 2026


October 2 2026

October 1 2026

September 30 2026

September 29 2026

September 28 2026

September 27 2026

September 25 2026

September 24 2026

September 23 2026

September 22 2026

September 21 2026